TET1 mutations in hematopoietic malignancy have a much lower frequency than TET2 mutations and their deletions cause different tumor types, suggesting that TET1 and TET2 are non-redundant and lineage-specific [83]. This evidence concerns the gene TET1 and neoplasm.